DAX22.272 +0,1%ESt505.170 +0,3%Top 10 Crypto12,13 -4,1%Dow40.228 +0,3%Nas17.366 -0,1%Bitcoin83.198 -0,1%Euro1,1379 -0,4%Öl65,35 -0,5%Gold3.311 -0,9%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 Tesla A1CX3T RENK RENK73 BYD A0M4W9 Lufthansa 823212 BASF BASF11 Mercedes-Benz Group (ex Daimler) 710000 Deutsche Telekom 555750 Siemens Energy ENER6Y Allianz 840400 Volkswagen (VW) vz. 766403 Amazon 906866 Bayer BAY001 Novo Nordisk A3EU6F
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt im Plus -- US-Börsen schließen uneinheitlich -- Akzo Nobel hat wohl Interesse an BASF-Lacke-Geschäft -- Merck: SpringWorks-Übernahme gesichert -- D-Wave Quantum, NVIDIA, Ripple im Fokus
Top News
NVIDIA-Aktie im Visier: Chinas Tech-Giganten sichern sich NVIDIA-Chips vor Exportstopp NVIDIA-Aktie im Visier: Chinas Tech-Giganten sichern sich NVIDIA-Chips vor Exportstopp
Apple-Aktie im Blick: Darum sollten sich Anleger auf eine Schwächephase einstellen Apple-Aktie im Blick: Darum sollten sich Anleger auf eine Schwächephase einstellen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Europäische Aktien bieten Grund für Optimismus. Ihre Aussichten könnten langfristig besser sein als für die erfolgsverwöhnten US-Titel. DWS informiert

DexCom Aktie

NeuKaufenVerkaufen
DexCom Aktien-Sparplan
62,90 EUR +0,02 EUR +0,03 %
STU
71,17 USD -0,49 USD -0,68 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.24,62 Mrd. EUR

KGV54,61Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA0D9T1

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS2521311074

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDXCM

DexCom Aktien News

DatumMeistgelesen
BusinesswireDexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook
BusinesswireDexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference
BusinesswireDexcom Launches the First Generative AI Platform in Glucose Biosensing
Wer­bungDexCom-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BusinesswireAlberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM
BusinesswireDexcom and OURA Announce Strategic Partnership
BusinesswireDexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
PR NewswireDXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
BusinesswireDexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
BusinesswireDexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
PR NewswireDXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
PR NewswireDXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
BusinesswireDexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
PR NewswireShareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
PR NewswireDexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM
PR NewswireDXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
BusinesswireDexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
BusinesswireDexcom Announces Upcoming Conference Presentation
PR NewswireDXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
BusinesswireStelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
PR NewswireDXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM
PR NewswireDXCM Notice of Investigation: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
BusinesswireRAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM
PR NewswireEdelson Lechtzin LLP Announces Investigation Dexcom, Inc. (NASDAQ: DXCM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
BusinesswireDexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
BusinesswireDexcom Expands AID Partnership Into The Netherlands
BusinesswireDexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
BusinesswireDexcom G7 Now Connects Directly to Apple Watch in the U.S.
BusinesswireDexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes
BusinesswireNova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
BusinesswireDexcom Announces Upcoming Conference Presentation
BusinesswireDexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
BusinesswireDexcom Reports First Quarter 2024 Financial Results
Wer­bung

DexCom News

DexCom News: auf dieser Seite finden Sie alle DexCom News und Nachrichten zur DexCom Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch DexCom News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um DexCom News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.